{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SIVBQ"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SIVBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SIVBQ\",,,,,undefined,":{"symbol":"SIVBQ","market":"US","secType":"STK","nameCN":"SVB Financial Group","latestPrice":0.006,"timestamp":1742414400000,"preClose":0.006,"halted":0,"volume":0,"delay":15,"changeRate":0,"change":0,"floatShares":53990110,"shares":59274992,"eps":25.35,"lyrEps":25.581907,"pbRate":0,"amount":0,"amplitude":0,"dividePrice":0,"prevYearClose":0.006,"fiveDayClose":0.006,"twentyDayClose":0.006},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SIVBQ\",,,,,undefined,":{"symbol":"SIVBQ","floatShares":53990110,"roa":"0.76%","roe":"9.78%","lyrEps":25.581907,"shares":59274992,"dividePrice":0,"high":0.006,"amplitude":0,"preClose":0.006,"low":0.006,"week52Low":0.0011,"pbRate":"0.00","psRate":"0.00","week52High":0.15,"institutionHeld":0,"latestPrice":0.006,"eps":25.35,"divideRate":0,"volume":0,"delay":15,"ttmEps":25.35,"open":0.006,"prevYearClose":0.006,"prevWeekClose":0.006,"prevMonthClose":0.006,"prevQuarterClose":0.006,"fiveDayClose":0.006,"twentyDayClose":0.006,"sixtyDayClose":0.006},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SIVBQ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-08","symbol":"SIVBQ","reason":null,"defaultRemindTime":1731076200000,"announcedDate":null,"type":"delisting","dateTimestamp":1731042000000},{"market":"US","date":"2023-10-19","symbol":"SIVBQ","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1697688000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SIVBQ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SIVBQ\",market:\"US\",delay:true,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SIVBQ\",params:#limit:6,delay:true,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SIVBQ\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518220467","title":"CORRECTED-UPDATE 1-Eli Lilly plans launch of weight-loss drug in emerging markets in 2025, CFO says","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220467","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518220467?lang=en_us&edition=fundamental","pubTime":"2025-03-10 22:17","pubTimestamp":1741616226,"startTime":"0","endTime":"0","summary":"CORRECTED-UPDATE 1-Eli Lilly plans launch of weight-loss drug in emerging markets in 2025, CFO saysCorrects headline and story to say the treatment will be launched in 2025, not 2026. March 10  - Eli Lilly LLY.N plans to launch its blockbuster diabetes and weight-loss drug, Mounjaro, in countries like China, India, Brazil and Mexico in 2025, Chief Financial Officer Lucas Montarce said on Monday.\"The size is significant. We're talking about 900 million patients that could benefit from Mounjaro,\" Montarce said at the Leerink Partners Global Healthcare Conference.Global demand for Lilly's and Danish rival Novo Nordisk's NOVOb.CO diabetes and weight-loss drugs has been extraordinary, with the two companies delaying their entry into new and emerging markets until they scaled up supply.Mounjaro, chemically known as tirzepatide, is currently sold in the UK and Europe under the same brand name for both diabetes and weightloss. However, it is sold under the brand name Zepbound for obesity in th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4N3PT13F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0097036916.USD","IE00B1BXHZ80.USD","IE00BJLML261.HKD","LU2357305700.SGD","LU2265009873.SGD","SGXZ31699556.SGD","SGXZ57979304.SGD","LU1720051108.HKD","SG9999014880.SGD","LU0354030438.USD","BK4581","SIVBQ","LU0708995401.HKD","LU1023059063.AUD","LU2468319806.SGD","IE00BK4W5M84.HKD","LU0672654240.SGD","LU2324357040.USD","LU1868837136.USD","LU2237443895.HKD","LU0820561818.USD","LU2361044949.HKD","BK4533","LU0256863902.USD","LU0256863811.USD","LU0466842654.USD","LU2237443622.USD","LU1983299246.USD","BK4516","LU0640476718.USD","LU1280957306.USD","BK4589","LU0823416689.USD","LU1267930730.SGD","LU2106854487.HKD","LLY","LU0354030511.USD","LU0106261372.USD","LU1974910355.USD","SG9999001176.SGD","LU0289739699.SGD","LU1804176565.USD","SG9999013999.USD","LU0820561909.HKD","LU2461242641.AUD","LU1868836591.USD","LU0114720955.EUR","LU0882574055.USD","LU1551013425.SGD","LU2360106947.USD"],"gpt_icon":1},{"id":"2518522204","title":"CORRECTED-Eli Lilly plans to launch Mounjaro in China, India, Brazil and Mexico in 2025, CFO says","url":"https://stock-news.laohu8.com/highlight/detail?id=2518522204","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518522204?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:48","pubTimestamp":1741614499,"startTime":"0","endTime":"0","summary":"CORRECTED-Eli Lilly plans to launch Mounjaro in China, India, Brazil and Mexico in 2025, CFO saysCorrects headline and story to say the treatment will be launched in 2025, not 2026March 10  - Eli Lilly LLY.N plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico in 2025, Chief Financial Officer Lucas Montarce said on Monday at the Leerink Partners Global Healthcare Conference.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4N3PT12I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261372.USD","LU2361044949.HKD","LU1064131342.USD","SG9999015945.SGD","SIVBQ","LU2089984988.USD","LU1280957306.USD","SG9999017495.SGD","LU0882574139.USD","LU2461242641.AUD","LU1720051017.SGD","SG9999015986.USD","LU0672654240.SGD","LU2491050154.USD","SG9999013999.USD","SGXZ57979304.SGD","LU2112291526.USD","LU2237438978.USD","LU0354030438.USD","LU0238689110.USD","LU1868836757.USD","SGXZ81514606.USD","SGXZ99366536.SGD","LU1814569148.SGD","LU1868837300.USD","LU1093756325.SGD","LU0466842654.USD","LU0058720904.USD","LU1868837136.USD","LU1720051108.HKD","SG9999001176.SGD","LU2237443549.SGD","LU1127390331.HKD","LU2360106947.USD","LU0823416689.USD","LU0114720955.EUR","LU1551013425.SGD","LLY","BK4516","SG9999014906.USD","LU2265009873.SGD","BK4588","LU2237443978.SGD","SG9999018865.SGD","BK4207","BK4599","BK4589","LU1023059063.AUD","LU2237443465.HKD","LU0122379950.USD"],"gpt_icon":0},{"id":"2518226308","title":"BUZZ-Eli Lilly falls after rival Novo Nordisk reports next-gen obesity drug data","url":"https://stock-news.laohu8.com/highlight/detail?id=2518226308","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518226308?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:43","pubTimestamp":1741610627,"startTime":"0","endTime":"0","summary":"BUZZ-Eli Lilly falls after rival Novo Nordisk reports next-gen obesity drug data** Shares of U.S. drugmaker Eli Lilly LLY.N fall 1.5% to $856.37 premarket** Danish rival Novo Nordisk NOVOb.CO reports late-stage data for its experimental next-generation weight-loss drug, CagriSema ** Says CagriSema helped overweight patients with type 2 diabetes  cut their weight by 15.7% after 68 weeks compared to 3.1% with placebo ** This compares to absolute weight loss of up to ~15.5% shown by LLY's obesity drug Zepbound in T2D patients at week 68 in a late-stage study - Brokerage Leerink Partners** The CagriSema weight loss data appears a comparable cross-trial to LLY's Zepbound, brokerage says** Up to last close, LLY stock had risen 11.5% in the past 12 months   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4N3PT0XF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2357305700.SGD","LU2361044865.SGD","LU1267930730.SGD","SG9999015952.SGD","SG9999014914.USD","LU1814569148.SGD","IE00BK4W5M84.HKD","LU0058720904.USD","LU2237443465.HKD","LU0466842654.USD","LU1988902786.USD","LU2491050154.USD","SIVBQ","LU0238689110.USD","LU1551013342.USD","SG9999014898.SGD","LU0097036916.USD","LU2106854487.HKD","LU0823416689.USD","BK4534","LU1093756325.SGD","LU2264538146.SGD","LU0882574139.USD","LLY","LU2237443978.SGD","LU2237443549.SGD","LU2237443622.USD","IE00B1BXHZ80.USD","LU1023059063.AUD","LU1069344957.HKD","IE00B2B36J28.USD","IE0004445239.USD","LU1291159041.SGD","BK4211","LU2602419157.SGD","LU1720051108.HKD","LU0114720955.EUR","LU1974910355.USD","LU0640476718.USD","SGXZ81514606.USD","LU0122379950.USD","LU1366192091.USD","LU1093756168.USD","SG9999014880.SGD","LU0354030511.USD","LU2324357040.USD","IE00BK4W5L77.USD","SG9999015986.USD","LU1127390331.HKD","LU1917777945.USD"],"gpt_icon":1},{"id":"2517229927","title":"Silicon Valley Bank's former parent sues to reclaim tarnished brand","url":"https://stock-news.laohu8.com/highlight/detail?id=2517229927","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517229927?lang=en_us&edition=fundamental","pubTime":"2025-03-06 06:21","pubTimestamp":1741213272,"startTime":"0","endTime":"0","summary":"Silicon Valley Bank's former parent sues to reclaim tarnished brandBy Jonathan Stempel","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL2N3PO16G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","FIZN","LU0072461881.USD","SG9999002232.USD","LU2756315318.SGD","IE00BDCRKT87.USD","LU0943347566.SGD","LU0787776722.HKD","BK4581","LU2237443978.SGD","LU0964807845.USD","LU1119994496.HKD","IE00BBT3K403.USD","IE00BN8TJ469.HKD","LU1244550577.SGD","LU1363072403.SGD","LU1894683348.USD","IE00BFXG1179.USD","LU1032466523.USD","SIVBQ","LU0070302665.USD","BK4550","LU2242649171.HKD","LU2756315664.SGD","LU2213496289.HKD","LU0971096721.USD","LU0006061336.USD","LU1084165304.USD","LU1551013342.USD","LU0320765646.SGD","LU0976567544.SGD","LU1720051017.SGD","LU1366192091.USD","LU2430703095.HKD","IE00BLSP4452.SGD","LU2237443382.USD","IE00B1XK9C88.USD","IE00BZ1G4Q59.USD","LU1244550494.USD","LU2237443622.USD","IE00BLSP4239.USD","BK4589","IE0034235295.USD","LU0417517546.SGD","BK4534","LU0208291251.USD","LU0211326839.USD","FCNCA","LU2505996509.AUD","LU0106831901.USD"],"gpt_icon":0}],"pageSize":4,"totalPage":12,"pageCount":1,"totalSize":46}]}}